In one word: Greed.
Single-payer systems uses master pricing lists to set the price of a treatment or service across the entire system. So, the pharmaceutical company can’t easily say no; otherwise, it would end up missing out on the market. Couple that with other factors, such as scale, simplified administration and a focus on patient outcomes over profits, and you have a system that isn’t incentivised to push prices as there are regulatory bodies keeping watch.
Latest Answers